mobile-logo

Diabetes Tag

07 Aug

What is the Impact of COVID-19 on Patients with Diabetes?

by Marianne Ryan
in Healthcare Data Management, Industry News, Life Sciences, Technology
Comments

MSA’s Healthcare Data Management experts provide solutions that empower pharma to better understand the impact of COVID-19 on the diabetes patient journey by linking clinical lab results, prescriptions, EMR, and medical claims data – all while protecting patient privacy. MSA, provider of the industry’s most credentialed, configurable, and trusted de-identification and data management solutions, accurately anonymizes and seamlessly links disparate data from one or multiple...

Read More
31 Jul

COVID-19 Impact on Recovered Patients with Chronic Diseases

by Marianne Ryan
in All, Industry News, Technology
Comments

A close examination of the COVID-19 patient journey will result in a better understanding of the impact of the virus on at-risk diabetes patients. Segmenting positive and negative COVID-19 patients provides a real world comparison of anonymized patient cohorts’ A1C, fasting blood sugars, and glucose levels. Linked with prescribed medications, this data will identify the impact of COVID-19 on the patients’ prescribed drug therapy. The...

Read More
MENU